Many of America’s poorest and sickest patients are stuck navigating two separate insurance programs — Medicare and Medicaid — to get the care they need.
Cost of Care
How Patents Help Keep Obesity Drug Prices Sky-High
A recent JAMA study sheds light on how the manufacturers of a class of popular weight-loss drugs have avoided competition from more affordable generics.
How Smartwatches Could Lead Doctors to Overtreat Patients
A new study suggests doctors struggle to know when and how to act on heart rhythm data generated by patients’ smartwatches.
Experts Share Four Key Studies you Might have Missed this Summer
Experts from the Tradeoffs Advisory Board share some of their favorite new health policy studies.
What to Expect When Medicare and Pharma Finally Negotiate Drug Prices
We explain how Medicare’s historic price negotiations with drugmakers will work, and the impact they could have.
Can Medicare Afford to Foot the Bill for New Alzheimer’s Drugs?
Recent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
How Charitable are Nonprofit Hospitals?
A new Health Affairs study finds that as nonprofit hospitals’ earnings grow, their charity care spending fails to keep pace.
One Economist’s Plan to Blow Up America’s Health Insurance System
Economist Amy Finkelstein has studied America’s patchwork of health insurance policies for more than 20 years. She’s finally concluded that it’s time to tear the whole system down.
The Wonky Policy That’s Got Hospitals on High Alert
Medicare could soon pay hospitals much less for common outpatient services like x-rays and checkups.
What we’ve learned from federal efforts to fight HIV/AIDS
A recent NBER working paper compares the impact of public health funding for HIV/AIDS to other federal programs.
